SUPN
Supernus Pharmaceuticals, Inc.
stockNASDAQ
At CloseOct 28, 2026 3:59:51 PM EDT
41.15USD+0.464%(+0.19)1,099,364
After-hoursOct 28, 2026 4:46:30 PM EDT
40.39USD-1.842%(-0.76)
SUPN Financials
In Q2 FY 2026 (ended ), Supernus Pharmaceuticals, Inc. (SUPN) reported revenue of $219.06M, net income of −$58.37M, operating cash flow of −$4.81M, and assets of $1.43B.
Loading business breakdowns…